Tag: drug development
Biogen-Denali Parkinson’s Drug Fails Phase 2 Trial, Highlighting Treatment Development Challenges
Biogen and Denali's experimental Parkinson's therapy failed Phase 2 trial endpoints, highlighting ongoing challenges in neurodegenerative disease drug development. The…
New R&D Ranking Reveals Sharp Disparities in Pharmaceutical Innovation Efficiency
A new evidence-based ranking of pharmaceutical companies reveals significant disparities in how efficiently firms convert R&D spending into drug approvals.…
Submit Your Paper to GMJ
No APC until January 2027.